Maravai Lifesciences Holdings, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
MRVI on Nasdaq
Location
10770 Wateridge Circle Suite 200, San Diego, CA

Insiders trading volume in the past year

Maravai Lifesciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gtcr Investment Xi Llc Director, 10%+ Owner $1.39B May 28, 2024
William E. Martin III Chief Executive Officer $4.79M Mar 17, 2025
Bernd Brust Chief Executive Officer, Director $3.96M Jun 8, 2025
Carl Hull Executive Chairman, Director $2.69M +$987K +57.9% Nov 11, 2024
Peter Leddy Chief Administrative Officer $1.88M Jul 15, 2025
Andrew Burch Former President, Nucleic Acid Production $1.68M Jan 15, 2025
Rebecca Buzzeo Chief Commercial Officer $1.6M Mar 17, 2025
Kurt Oreshack General Counsel $1.21M -$126K -9.44% Mar 17, 2025
Kevin Herde Chief Financial Officer $1.13M May 15, 2025
Rajesh Asarpota Chief Financial Officer $990K Jun 30, 2025
Christine Dolan Executive Vice President & General Manager, Cygnus Technologies $791K May 15, 2025
R. Andrew Eckert Director $790K Jun 16, 2025
Anat Ashkenazi Director $655K May 23, 2024
Jessica Hopfield Director $432K Jun 16, 2025
Susannah Gray Director $367K Jun 16, 2025
John DeFord Director $344K +$101K +41.4% Jun 16, 2025
Murali Prahalad Director $334K Jun 16, 2025
Gregory T. Lucier Director $327K Jul 10, 2025
Sean Cunningham Director $298K Jun 16, 2025
Constantine Mihas Director $298K Jun 16, 2025
Luke Marker Director $298K Jun 16, 2025
Benjamin Daverman Director $298K Jun 16, 2025
Robert B. Hance Director $136K Nov 19, 2021
Brian Neel Chief Operating Officer, Nucleic Acid Production $85.5K Feb 15, 2023

Recent Insider Transactions by Companies or Individuals for Maravai Lifesciences Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.